Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-03-08 00:00:00 ET · period of report 2024-03-06 · accession 0000950170-24-028807 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-03-08 | 2024-03-06+ | TYRA | Bensen Daniel | COO | S - Sale | $20.09 | -1,801 | 431.9K | -0.4% | -$36.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-06 | S | D | 1,733 | $20.09 | 431,951 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.39. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 2 | Common | Common Stock | 2024-03-07 | S | D | 68 | $20.00 | 431,883 | D | — | — |